Hisam Siddiqi: A Helpful Clinical Framework for Understanding Eosinophilia
Hisam Siddiqi, Consultant Haematologist at LycaHealth, The Blackheath Hospital, Dartford and Gravesham NHS Trust, shared a post on LinkedIn:
“Understanding Eosinophilia: A Helpful Clinical Framework
Eosinophilia is a common yet often misunderstood finding in clinical practice.
My infographic below beautifully summarises the secondary causes of eosinophilia, offering a clear way to organise our thinking when approaching patients with raised eosinophil counts.
From parasitic infections and allergic conditions, through to autoimmune disease, endocrine disorders, skin disease, and haematological malignancies, the differential is wide — and a structured approach is essential for timely diagnosis.
Key categories
- Parasitic and Fungal Infections
Examples include roundworm infections, trichinosis, ascariasis and other parasitic processes.
- Allergies
Hay fever, asthma, atopic dermatitis, and drug-related hypersensitivity reactions are frequent culprits.
- Autoimmune Disorders
Conditions such as eosinophilic gastrointestinal disorders, inflammatory bowel disease, and eosinophilic vasculitides appear in this group.
- Endocrine Disorders
Adrenal-related issues, including Addison’s disease, can also drive persistent eosinophilia.
- Skin Conditions
Several dermatological conditions are known associations and warrant consideration.
- Cancers
A reminder that eosinophilia may be associated with haematological disease such as Hodgkin and non-Hodgkin lymphoma, chronic myeloid processes, and systemic mast cell disorders.
Why it matters:
A systematic approach ensures we don’t miss reversible causes while also being vigilant for serious underlying disease.
This type of visual framework is a great tool for trainees and clinicians across specialties.
If you see eosinophilia — think broadly, investigate wisely, and always contextualize clinically.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls